[Antibiotic therapy: progress and development of resistance]

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Context:

• Rising prevalence of antibiotic resistance in gram-positive bacteria, including Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE).
• Increasing challenge for clinicians in effectively treating multidrug-resistant (MDR) bacterial infections.
• Need for updated therapeutic strategies and novel antimicrobial agents.

Purpose:

• To elucidate the reasons, spread, and mechanisms behind the development of resistance in gram-positive microorganisms.
• To explore strategies for overcoming existing resistance and outline new antibacterial therapies.
• To compare resistance patterns in hospital versus community settings and their clinical implications.

Summary:

• Details the emergence and mechanisms of resistance in key gram-positive pathogens like MRSA and VRE.
• Introduces recently developed antibiotics—linezolid (oxazolidinone), daptomycin (lipopeptide), and tigecycline (glycylcycline)—as potential treatments for MDR infections.
• Highlights the differences in resistance prevalence between hospital and community environments, emphasizing relevance for internal medicine.

Impact:

• Provides insights into managing antibiotic resistance, crucial for internal medicine physicians.
• Informs clinical practice regarding the use of novel antibiotics against challenging gram-positive infections.
• Contributes to the understanding of antimicrobial resistance evolution and management strategies.